c-Myc target genes involved in cell growth, apoptosis, and metabolism

Molecular and Cellular Biology

Volumn 19, Issue 1, 1999, Pages 1-11

  Dang, Chi V ^a,b  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b Ross Research Building ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSCRIPTION FACTOR;

APOPTOSIS; CELL CYCLE; CELL GROWTH; CELL IMMORTALIZATION; CELL METABOLISM; GENE EXPRESSION; HUMAN; MALIGNANT TRANSFORMATION; ONCOGENE C MYC; POINT MUTATION; PRIORITY JOURNAL; REVIEW; TRANSCRIPTION REGULATION;

EID: 0032905924     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.19.1.1     Document Type: Review

References (207)

1. Adams, J. M., and S. Cory. 1991. Transgenic models of tumur development. Science 254:1161-1167.
2. Afar, D. E., A. Goga, J. McLaughlin, O. N. Witte, and C. L. Sawyers. 1994. Differential complementation of Bcr-Abl point mutants with c-Myc. Science 264:424-426.
3. Albarosa, R., S. DiDonato, and G. Finocchiaro. 1995. Redefinition of the coding sequence of the MXl1 gene and identification of a polymorphic repeat in the 3′ non-coding region that allows the detection of loss of heterozygosity of chromosome 10q25 in glioblastomas. Hum. Genet. 95: 709-711.
4. Alland, L., R. Muhle, H. Hou, Jr., J. Potes, L. Chin, N. Schreiber-Agus, and R. A. DePinho. 1997. Role for N-CoR and histone deacetylase in Sin3-mediated transcriptional repression. Nature 387:49-55.
5. Amati, B., K. Alevizopoulos, and J. Vlach. 1998. Myc and the cell cycle. Front. Biosci. 3:D250-D268.
6. Amati, B., S. Dalton, M. W. Brooks, T. D. Littlewood, G. I. Evan, and H. Land. 1992. Transcriptional activation by the human c-Myc oncoprotein in yeast requires interaction with Max. Nature 359:423-426.
7. Amin, C., A. J. Wagner, and N. Hay. 1993. Sequence-specific transcriptional activition by Myc and repression by Max. Mol. Cell. Biol. 13:383-390.
8. Askew, D. S., R. A. Ashmun, B. C. Simmons, and J. L. Cleveland. 1991. Constitutive c-myc expression in an IL-3-dependent myeloid cell line suppresses cell cycle arrest and accelerates apoptosis. Oncogene 6:1915-1922.
9. Augenlicht, L. H., S. Wadler, G. Corner, C. Richards, L. Ryan, A. S. Mullani, S. Pathak, A. Benson, D. Haller, and B. G. Heerdt. 1997. Low-level c-myc amplification in human colonic carcinoma cell lines and tumors: a frequent, p53-independent mutation associated with improved outcome in a randomized multi-institutional trial. Cancer Res. 57:1769-1775.
10. Austen, M., C. Cerni, J. M. Luscher-Firzlaff, and B. Luscher. 1998. YY1 can inhibit c-Myc function through a mechanism requiring DNA binding of YY1 but neither its transactivation domain nor direct interaction with c-Myc. Oncogene 17:511-520.
11. Ayer, D. E., L. Kretzner, and R. N. Eisenman. 1993. Mad: a heterodimeric partner for Max that antagonizes Myc transcriptional activity. Cell 72:211-222
12. Ayer, D. E., Q. A. Lawrence, and R. N. Eisenman. 1995. Mad Max transcriptional repression is mediated by ternary complex formation with mammalian homologs of yeast repressor Sin3. Cell 80:767-776.
13. Barone, M. V., and S. A. Courtneidge. 1995. Myc but not Fos rescue of PDGF signalling block caused by kinase-inactive Src. Nature 378:509-512.
14. Bartsch, D., S. L. Peiffer, Z. Kaleem, S. Wells, Jr., and P. J. Goodfellow. 1996. Mxi1 tumor suppressor gene is not mutated in primary pancreatic adenocarcinoma. Cancer Lett. 102:73-76.
15. Battey, J., C. Moulding, R. Taub, W. Murphy, T. Stewart, H. Potter, G. Lenoir, and P. Leder. 1983. The human c-myc oncogene: structural consequences of translocation into the IgH locus in Burkitt lymphoma. Cell 34:779-787.
16. Beckmann, H., L. K. Su, and T. Kadesch. 1990. TFE3: a helix-loop-helix protein that activates transcription through the immunoglobulin enhancer muE3 motif. Genes Dev. 4:167-179.
17. Beijersbergen, R. L., E. M. Hijmans, L. Zhu, and R. Bernards. 1994. Interaction of c-Myc with the pRb-related protein p107 results in inhibition of c-Myc-mediated transactivation. EMBO J. 13:4080-4086.
18. Bello-Kernandez, C., G. Packham, and J. L. Cleveland. 1993. The ornithine decarboxylase gene is a transcriptional target of c-Myc. Proc. Natl. Acad. Sci. USA 90:7804-7808.
19. Benvenisty, N., A. Leder, A. Kuo, and P. Leder. 1992. An embryonically expressed gene is a target for c-Myc regulation via the c-Myc-binding sequence. Genes Dev. 6:2513-2523.
20. Berberich, S. J., and M. D. Cole. 1992. Casein kinase II inhibits the DNA-binding activity of Max homodimers but not Myc/Max heterodimers. Genes Dev. 6:166-176.
21. Bhatia, K., K. Huppi, G. Spangler, D. Siwarski, R. Iyer, and I. Magrath. 1993. Point mutations in the c-Myc transactivation domain are common in Burkitt's lymphoma and mouse plasmacytoma. Nat. Genet. 5:56-61.
22. Bhatia, K., G. Spangler, G. Gaidano, N. Hamdy, R. Dalla-Favera, and I. Magrath. 1994. Mutations in the coding region of c-myc occur frequently in acquired immunodeficiency syndrome-associated lymphomas. Blood 84:883-888.
23. Bishop, J. M. 1982. Retroviruses and cancer genes. Adv. Cancer Res. 37: 1-32.
24. Bissonette, R., F. Echeverri, A. Mahboubi, and D. Green. 1992. Apoptotic cell death induced by c-myc is inhibited by bcl-2. Nature 359:552-554.
25. Bister, K., and H. W. Jansen. 1986. Oncogenes in retroviruses and cells: biochemistry and molecular genetics. Adv. Cancer Res. 47:99-188.
26. Blackwell, T. K., J. Huang, A. Ma, L. Kretzner, F. W. Alt, R. N. Eisenman, and H. Weintraub. 1993. Binding of Myc proteins to canonical and noncanonical DNA sequences. Mol. Cell. Biol. 13:5216-5224.
27. Blackwell, T. K., L. Kretzner, E. M. Blackwood, R. N. Eisenman, and H. Weintraub. 1990. Sequence-specific DNA binding by the c-Myc protein. Science 250:1149-1151.
28. Blackwood, E. M., and R. N. Eisenman. 1991. Max: a helix-loop-helix zipper protein that forms a sequence-specific DNA-binding complex with Myc. Science 251:1211-217.
29. Blackwood, E. M., L. Kretzner, and R. N. Eisenman. 1992. Myc and Max function as a nucleoprotein complex. Curr. Opin. Genet. Dev. 2:227-235.
30. Born, T. L., J. A. Frost, A. Schönthal, G. C. Prendergast, and J. R. Feramisco. 1994. C-Myc cooperates with activated Ras to induce the cdc2 promoter. Mol. Cell. Biol. 14:5710-5718.
31. Bourgeade, M. F., A. S. Defachelles, and Y. E. Cayre. 1998. Myc is essential for transformation by TEL/platelet-derived growth factor receptor beta (PDGFRbeta). Blood 91:3333-3339.
32. Brand, K. A., and U. Hermfisse. 1997. Aerobic glycolysis by proliferating cells: a protective strategy against reactive oxygen species. FASEB J. 11: 388-395.
33. Cadigan, K. M., and R. Nusse. 1997. Wnt signaling: a common theme in animal development. Genes Dev. 11:3286-3305.
34. Chou, T. Y., C. V. Dang, and G. W. Hart. 1995. Glycosylation of the c-Myc transactivation domain. Proc. Natl. Acad. Sci. USA 92:4417-4421.
35. Chou, T. Y., G. W. Hart, and C. V. Dang. 1995. c-Myc is glycosylated at threonine-58, a known phosphorylation site and a mutational hot spot in lymphomas. J. Biol. Chem. 270:18961-18965.
36. Clark, H. M., T. Yano, T. Otsuki, E. S. Jaffe, D. Shibata, and M. Raffeld. 1994. Mutations in the coding region of c-myc in AIDS-associated and other aggressive lymphomas. Cancer Res. 54:3383-3386.
37. Cole, M. D. 1986. The myc oncogene: its role in transformation and differentiation. Annu. Rev. Genet. 20:361-384.
38. Daksis, J. I., R. Y. Lu, L. M. Facchini, W. W. Marhin, and L. J. Penn. 1994. Myc induces cyclin D1 expression in the absence of de novo protein synthesis and links mitogen-stimulated signal transduction to the cell cycle. Oncogene 9:3635-3645.
39. Dalla-Favera, R., E. P. Gelmann, S. Martinotti, G. Franchini, T. S. Papas, R. C. Gallo, and F. Wong-Staal. 1982. Cloning and characterization of different human sequences related to the one gene (v-myc) of avian myelo-cytomatosis virus (MC29). Proc. Natl. Acad. Sci. USA 79:6497-6501.
40. Dang, C. V. 1991. c-myc oncoprotein function. Biochim. Biophys. Acta 1072:103-113.
41. Dang, C. V., C. Dolde, M. L. Gillison, and G. J. Kato. 1992. Discrimination between related DNA sites by a single amino acid residue of Myc-related basic-helix-loop-helix proteins. Proc. Natl. Acad. Sci. USA 89:599-602.
42. Dang, C. V., and L. A. Lee. 1995. c-Myc function in neoplasia. R. G. Landes and Springer-Verlag, Austin, Tex.
43. Davis, A. C., M. Wims, G. D. Spotts, S. R. Hann, and A. Bradley. 1993. A null c-myc mutation causes lethality before 10.5 days of gestation in homozygotes and reduced fertility in heterozygous female mice. Genes Dev. 7:671-682.
44. DePinho, R. A., N. Schreiber-Agus, and F. W. Alt. 1991. myc family oncogenes in the development of normal and neoplastic cells. Adv. Cancer Res. 57:1-46.
45. Dong, Q. P., E. E. Blatter, Y. W. Ebright, K. Bister, and R. H. Ebright. 1994. Identification of amino acid base contacts in the myc DNA complex by site-specific bromouracil mediated photocrosslinking. EMBO J. 13:200-204.
46. Eagle, L. R., X. Yin, A. R. Brothman, B. J. Williams, N. B. Atkin, and E. V. Prochownik. 1995. Mutation of the MXI1 gene in prostate cancer. Nat Genet. 9:249-255.
47. Edelhoff, S., D. E. Ayer, A. S. Zervos, E. Steingrimsson, N. A. Jenkins, N. G. Copeland, R. N. Eisenman, R. Brent, and C. M. Disteche. 1994. Mapping of two genes encoding members of a distinct subfamily of MAX interacting proteins: MAD to human chromosome 2 and mouse chromosome 6, and MXI1 to human chromosome 10 and mouse chromosome 19. Oncogene 9:665-668.
48. Eilers, M., S. Schirm, and J. M. Bishop. 1991. The MYC protein activates transcription of the alpha-prothymosin gene. EMBO J. 10:133-141.
49. Erisman, M. D., P. G. Rothberg, R. E. Diehl, C. C. Morse, J. M. Spandorfer, and S. M. Astrin. 1985. Deregulation of c-myc gene expression in human colon carcinoma is not accompanied by amplification or rearrangement of the gene. Mol. Cell. Biol. 5:1969-1976.
50. Escot, C., C. Theillet, R. Lidereau, F. Spyratos, M. H. Champeme, J. Gest, and R. Callahan. 1986. Genetic alteration of the c-myc protooncogene (MYC) in human primary breast carcinomas. Proc. Natl. Acad. Sci. USA 83:4834-4838.
51. Evan, G., and T. Littlewood. 1998. A matter of life and cell death. Science 281:1317-1322.
52. Evan, G. I., and T. D. Littlewood. 1993. The role of c-myc in cell growth. Curr. Opin. Genet. Dev. 3:44-49.
53. Evan, G. I., A. H. Wyllie, C. S. Gilbert, T. D. Littlewood, H. Land, M. Brooks, C. M. Waters, L. Z. Penn, and D. C. Hancock. 1992. Induction of apoptosis in fibroblasts by c-myc protein. Cell 69:119-128.
54. Facchini, L. M., and L. Z. Penn. 1998. The molecular role of Myc in growth and transformation: recent discoveries lead to new insights. FASEB J. 12:633-651.
55. Fanidi, A., E. A. Harrington, and G. I. Evan. 1992. Cooperative interaction between c-myc and bcl-2 proto-oncogenes. Nature 359:554-556.
56. Ferre-D'Amare, A. R., P. Pognonec, R. G. Roeder, and S. K. Burley. 1994. Structure and function of the b/HLH/Z domain of USF. EMBO J. 13:180-189.
57. Ferre-D'Amare, A. R., G. C. Prendergast, E. B. Ziff, and S. K. Burley. 1993. Recognition by Max of its cognate DNA through a dimeric b/HLH/Z domain. Nature 363:38-45.
58. Firth, J. D., B. L. Ebert, and P. J. Ratcliffe. 1995. Hypoxic regulation of lactate dehydrogenase A. Interaction between hypoxia-inducible factor I and cAMP response elements. J. Biol. Chem. 270:21021-21027.
59. Fisher, D. E., C. S. Carr, L. A. Parent, and P. A. Sharp. 1991. TFEB has DNA-binding and oligomerization properties of a unique helix-loop-helix/leucine-zipper family. Genes Dev. 5:2342-2352.
60. Fisher, F., P. S. Jayaraman, and C. R. Goding. 1991. C-myc and the yeast transcription factor PHO4 share a common CACGTG-binding motif. Oncogene 6:1099-1104.
61. Flinn, E. M., C. M. C. Busch, and A. P. H. Wright. 1998. myc boxes, which are conserved in myc family proteins, are signals for protein degradation via the proteasome. Mol. Cell. Biol. 18:5961-5969.
62. Foley, K. P., G. A. McArthur, C. Queva, P. J. Hurlin, P. Soriano, and R. N. Eisenman. 1998. Targeted disruption of the MYC antagonist MAD1 inhibits cell cycle exit during granulocyte differentiation. EMBO J. 17:774-785.
63. 1. Mol. Cell. Biol. 8:1614-1624.
64. Galaktionov, K., X. Chen, and D. Beach. 1996. Cdc25 cell-cycle phosphatase as a target of c-myc. Nature 382:511-517.
65. Gaubatz, S., F. A. Imho, H. Dosch, R. O. Werne, P. Mitchell, R. R. Buettne, and M. Eilers. 1995. Transcriptional activation by Myc is under negative control by the transcription factor AP-2. EMBO J. 14:1508-1519.
66. Grandori, C., and R. N. Eisenman. 1997. Myc target genes. Trends Biochem. Sci. 22:177-181.
67. Grandori, C., J. Mac, F. Siebelt, D. E. Ayer, and R. N. Eisenman. 1996. Myc-Max heterodimers activate a DEAD box gene and interact with multiple E box-related sites in vivo. EMBO J. 15:4344-4357.
68. Gray, I. C., S. M. Phillips, S. J. Lee, J. P. Neoptolemos, J. Weissenbach, and N. K. Spurr. 1995. Loss of the chromosomal region 10q23-25 in prostate cancer. Cancer Res. 55:4800-4803.
69. Gregor, P. D., M. Sawadogo, and R. G. Roeder. 1990. The adenovirus major late transcription factor USF is a member of the helix-loop-helix group of regulatory proteins and binds to DNA as a dimer. Genes Dev. 4:1730-1740.
70. Greiner, E. F., M. Guppy, and K. Brand. 1994. Glucose is essential for proliferation and the glycolytic enzyme induction that provokes a transition to glycolytic energy production. J. Biol. Chem. 269:31484-31490.
71. Gu, W., K. Bhatia, I. T. Magrath, C. V. Dang, and R. Dalla-Favera. 1994. Binding and suppression of the Myc transcriptional activation domain by p107. Science 264:251-254.
72. Gu, W., K. Cechova, V. Tassi, and R. Dalla-Favera. 1993. Opposite regulation of gene transcription and cell proliferation by c-Myc and Max. Proc. Natl. Acad. Sci. USA 90:2935-2939.
73. Guo, Q., J. Xie, C. V. Dang, E. T. Liu, and J. M. Bishop. 1998. Identification of a large Myc-binding protein that contains RCC1-like repeats. Proc. Natl. Acad. Sci. USA 95:9172-9177.
74. Haas, K., P. Staller, C. Geisen, J. Bartek, M. Eilers, and T. Moroy. 1997. Mutual requirement of CDK4 and Myc in malignant transformation: evidence for cyclin D1/CDK4 and p16INK4A as upstream regulators of Myc. Oncogene 15:179-192.
75. Hann, S. R., M. Dixit, R. C. Sears, and L. Sealy. 1994. The alternatively initiated c-Myc proteins differentially regulate transcription through a non-canonical DNA-binding site. Genes Dev. 8:2441-2452.
76. Hann, S. R., K. Sloan-Brown, and G. D. Spotts. 1992. Translational activation of the non-AUG-initiated c-myc 1 protein at high cell densities due to methionine deprivation. Genes Dev. 6:1229-1240.
77. Hanson, K. D., M. Shichiri, M. R. Follansbee, and J. M. Sedivy. 1994. Effects of c-myc expression on cell cycle progression. Mol. Cell. Biol. 14: 5748-5755.
78. Harper, S. E., Y. Qiu, and P. A. Sharp. 1996. Sin3 corepressor function in Myc-induced transcription and transformation. Proc. Natl. Acad. Sci. USA 93:8536-8540.
79. Hateboer, G., H. T. Timmers, A. K. Rustgi, M. Billaud, L. J. van't Veer, and R. Bernards. 1993. TATA-binding protein and the retinoblastoma gene product bind to overlapping epitopes on c-Myc and adenovirus E1A protein. Proc. Natl. Acad. Sci. USA 90:8489-8493.
80. He, T. C., A. B. Sparks, C. Rago, H. Hermeking, L. Zawel, L. T. da Costa, P. J. Morin, B. Vogelstein, and K. W. Kinzler. 1998. Identification of c-MYC as a target of the APC pathway. Science 281:1509-1512.
81. Heinzel, T., R. M. Lavinsky, T. M. Mullen, M. Soderstrom, C. D. Laherty, J. Torchia, W. M. Yang, G. Brard, S. D. Ngo, J. R. Davie, E. Seto, R. N. Eisenman, D. W. Rose, C. K. Glass, and M. G. Rosenfeld. 1997. A complex containing N-CoR, mSin3 and histone deacetylase mediates transcriptional repression. Nature 387:43-48.
82. Henriksson, M., and B. Luscher. 1996. Proteins of the Myc network: essential regulators of cell growth and differentiation. Adv. Cancer Res. 68:109-182.
83. Hermeking, H., and D. Eick. 1994. Mediation of c-myc-induced apoptosis by p53. Science 265:2091-2093.
84. Hoang, A. T., K. J. Cohen, J. F. Barrett, D. A. Bergstrom, and C. V. Dang. 1994. Participation of cyclin A in Myc-induced apoptosis. Proc. Natl. Acad. Sci. USA 91:6875-6879.
85. Hoang, A. T., B. Lutterbach, B. C. Lewis, T. Yano, T.-Y. Chou, J. F. Barrett, M. Raffeld, S. R. Hann, and C. V. Dang. 1995. A link between increased transforming activity of lymphoma-derived MYC mutant alleles, their defective regulation hy p107, and altered phosphorylation of the c-Myc transactivation domain. Mol. Cell. Bid. 15:4031-4042.
86. Hueber, A., M. Zornig, D. Lyon, T. Suda, S. Nagata, and G. I. Evan. 1997. Requirement for the CD95 receptor-ligand pathway in c-Myc-induced apoptosis. Science 278:1305-1309.
87. Hurlin, P. J., K. P. Foley, D. E. Ayer, R. N. Eisenman, D. Hanahan, and J. M. Arbeit. 1995. Regulation of Myc and Mad during epidermal differentiation and HPV-associated tumorigenesis. Oncogene 11:2487-2501.
88. Hurlin, P. J., C. Queva, and R. N. Eisenman. 1997. Mnt. a novel Max-interacting protein, is coexpressed with Myc in proliferating cells and mediates repression at Myc binding sites. Genes Dev. 11:44-58.
89. Hurlin, P. J., C. Queva, P. J. Koskinen, E. Steingrimsson, D. E. Ayer, N. G. Copeland, N. A. Jenkins, and R. N. Eisenman. 1995. Mad3 and Mad4: novel Max-interacting transcriptional repressors that suppress c-myc dependent transformation and are expressed during neural and epidermal differentiation. EMBO J. 14:5646-5659.
90. Inghirami, G., F. Grignani, L. Sternas, L. Lombardi, D. M. Knowles, and R. Dalla-Favera. 1990. Down-regulation of LFA-1 adhesion receptors by c-myc oneogene in human B lymphoblastoid cells. Science 250:682-686.
91. Jansen-Durr, P., A. Meichle, P. Steiner, M. Pagano, D. Finke, J. Botz, J. Wessbecher, G. Draetta, and M. Eilers. 1993. Differential modulation of cyclin gene expression hy MYC. Proc. Natl. Acad. Sci. USA 90:3685-3689.
92. Jones, R. M., J. Branda, K. A. Johnston, M. Polymenis, M. Gadd, A. Rustgi, L. Callanan, and E. V. Schmidt. 1996. An essential E box in the promoter of the gene encoding the mRNA cap-binding protein (eukaryolic initiation factor 4E) is a target for activation by c-myc. Mol. Cell. Biol. 16:4754-4764.
93. Kato, G. J., J. Barrett, M. Villa-Garcia, and C. V. Dang. 1990. An amino-terminal c-Myc domain required for neoplastic transformation activates transcription. Mol. Cell. Biol. 10:5914-5920.
94. Kato, G. J., and C. V. Dang. 1992. Function of the c-Myc oncoprotein. FASEB J. 6:3065-3072.
95. Kato, G. J., W. M. Lee, L. L. Chen, and C. V. Dang. 1992. Max: functional domains and interaction with c-Myc. Genes Dev. 6:81-92.
96. Kawamata, N., D. Park, S. Wilczynski, J. Yokota, and H. P. Koeffler. 1996. Point mutations of the Mxi1 gene are rare in prostate cancers. Prostate 29:191-193.
97. Koskinen, P. J., I. Vastrik, T. P. Makela, R. N. Eisenman, and K. Alitalo. 1994. Max activity is affected by phosphorylation at two nh2-terminal sites. Cell Growth Differ. 5:313-320.
98. Kretzner, L., E. M. Blackwood, and R. N. Eisenman. 1992. Myc and Max proteins possess distinct transcriptional activities. Nature 359:426-429.
99. Land, H., L. F. Parada, and R. A. Weinberg. 1983. Tumorigenic conversion of primary embryo fibroblasts requires at least two cooperating oncogenes. Nature 304:596-602.
100. Lee, L. A., C. Dolde, J. Barrett, C. S. Wu, and C. V. Dang. 1996. A link between c-Myc-mediated transcriptional repression and neoplastic transformation. J. Clin. Investig. 97:1687-1695.
101. Lee, L. A., L. M. Resar, and C. V. Dang. 1995. Cell density and paradoxical transcriptional properties of c-Myc and Max in cultured mouse fibroblasts. J. Clin. Investig. 95:900-904.
102. Lemaitre, J. M., R. S. Buckle, and M. Mechali. 1996. c-Myc in the control of cell proliferation and embryonic development. Adv. Cancer Res. 70:95-144.
103. Leone, G., J. DeGregori, R. Sears, L. Jakoi, and J. R. Nevins. 1997. Myc and Ras collaborate in inducing accumulation of active cyclin E/Cdk2 and E2F. Nature 387:422-426.
104. Lewis, B. C., H. Shim, Q.Li, C. S. Wu, L. A. Lee, A. Maity, and C. V. Dang. 1997. Identification of putative c-Myc-responsive genes: characterization of rcl, a novel growth-related gene. Mol. Cell. Biol. 17:4967-4978.
105. Li, J., C. Yen, D. Liaw, K. Podsypanina, S. Bose, S. I. Wang, J. Puc, C. Miliaresis, L. Rodgers, R. McCombie, S. H. Bigner, B. C. Giovanella, M. Ittmann, B. Tycko, H. Hibshoosh, M. H. Wigler, and R. Parsons. 1997. PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science 275:1943-1947.
106. Li, L. H., C. Nerlov, G. Prendergast, D. MacGregor, and E. B. Ziff. 1994. c-Myc repressses transcription in vivo by a novel mechanism dependent on the initiator element and Myc box II. EMBO J. 13:4070-4079.
107. Litlle, C. D., M. M. Nau, D. N. Carney, A. F. Gazdar, and J. D. Minna. 1983. Amplification and expression of the c-myc oncogene in human lung cancer cell lines. Nature 306:194-196.
108. Littlewood, T. D., B. Amati, H. Land, and G. I. Evan. 1992. Max and c-Myc/Max DNA-binding activities in cell extracts. Oncogene 7:1783-1792.
109. Liu, Z., K. S. Thompson, and H. C. Towle. 1993. Carbohydrate regulation of the rat L-type pyruvate kinase gene requires two nuclear factors: LF-A1 and a member of the c-myc family. J. Biol. Chem. 268:12787-12795.
110. Luscher, B., and R. N. Eisenman. 1992. Mitosis-specific phosphorylation of the nuclear oncoproteins Myc and Myb. J. Cell Biol. 118:775-784.
111. Luscher, B., E. A. Kuenzel, E. G. Krebs, and R. N. Eisenman. 1989. Myc oncoproteins are phosphorylated by casein kinase II. EMBO J. 8:1111-1119.
112. Lutterbach, B., and S. R. Hann. 1994. Hierarchical phosphorylation at N-terminal transformation-sensitive sites in c-Myc protein is regulated by mitogens and in mitosis. Mol. Cell. Biol. 14:5510-5522.
113. Maheswaran, S., H. Lee, and G. E. Sonenshein. 1994. Intracellular association of the protein product of the c-myc oncogene with the TATA-binding protein. Mol. Cell. Biol. 14:1147-1152.
114. Mai, S., M. Fluri, D. Siwarski, and K. Huppi. 1996. Genomic instability in MycER-activated Rat1A-MycER cells. Chromosome Res. 4:365-371.
115. Mai, S., J. Hanley-Hyde, and M. Fluri. 1996. c-Myc overexpression associated DHFR gene amplification in hamster, rat, mouse and human cell lines. Oncogene 12:277-288.
116. Mai, S., and A. Jalava. 1994. C-myc binds to 5′ flanking sequence motifs of the dihydrofolate reductase gene in cellular extracts - role in proliferation. Nucleic Acids Res. 22:2264-2273.
117. Mai, S., and I. L. Martensson. 1995. The c-myc protein represses the lambda 5 and TdT initiators. Nucleic Acids Res. 23:1-9.
118. Marcu, K., S. Bossone, and A. Patel. 1992. Myc function and regulation. Annu. Rev. Biochem. 61:809-860.
119. Marhin, W. W., S. Chen, L. M. Facchini, A. J. Fornace, Jr., and L. Z. Penn. 1997. Myc represses the growth arrest gene gadd45. Oncogene 14:2825-2834.
120. Mariani-Costantini, R., C. Escot, C. Theillet, A. Gentile, G. Merlo, R. Lidereau, and R. Callahan. 1988. In situ c-myc expression and genomic status of the c-myc locus in infiltrating ductal carcinomas of the breast. Cancer Res. 48:199-205.
121. Mateyak, M. K., A. J. Obaya, S. Adachi, and J. M. Sedivy. 1997. Phenotypes of c-Myc-deficient rat fibroblasts isolated by targeted homologous recombination. Cell Growth Differ. 8:1039-1048.
122. Mathupala, S. P., A. Rempel, and P. L. Pedersen. 1995. Glucose catabolism in cancer cells. Isolation, sequence, and activity of the promoter for type II hexokinase. J. Biol. Chem. 270:16918-16925.
123. McEwan, I. J., K. Dahlman-Wright, J. Ford, and A. P. H. Wright. 1996. Functional interactions of the c-Myc transactivation domain with the TATA binding protein: evidence for an induced fit model of transactivation domain folding. Biochemistry 35:9584-9593.
124. McMahon, S. B., H. A. Van Buskirk, K. A. Dugan, T. D. Copeland, and M. D. Cole. 1998. The novel ATM-related protein TRRAP is an essential cofactor for the c-Myc and E2F oncoproteins. Cell 94:363-374.
125. Meichle, A., A. Philipp, and M. Eilers. 1992. The functions of Myc proteins. Biochim. Biophys. Acta 1114:129-146.
126. 1/S-phase boundary is suppressed by inhibitory c-Myc mutants. Mol. Cell. Biol. 15:2527-2535.
127. Mink, S., B. Mutschler, R. Weiskirchen, K. Bister, and K. H. Klempnauer. 1996. A novel function for Myc: inhibition of C/EBP-dependent gene activation. Proc. Natl. Acad. Sci. USA 93:6635-6640.
128. Munzel, P., D. Marx, H. Kochel, A. Schauer, and K. W. Bock. 1991. Genomic alterations of the c-myc protooncogene in relation to the overexpression of c-erbB2 and Ki-67 in human breast and cervix carcinomas. J. Cancer Res. Clin. Oncol. 117:603-607.
129. Nagy, L., H. Y. Kao, D. Chakravarti, R. J. Lin, C. A. Hassig, D. E. Ayer, S. L. Schreiber, and R. M. Evans. 1997. Nuclear receptor repression mediated by a complex containing SMRT, mSin3A, and histone deacelylase. Cell 89:373-380.
130. Nozaki, N., T. Naoe, and T. Okazaki. 1997. Immunoaffinity purification and characterization of CACGTG sequence-bindine proteins from cultured mammalian cells using an anti-c-Myc monoclonal antibody recognizing the DNA-binding domain. J. Biochem. 121:550-559.
131. Packham, G., C. Bellofernandez, and J. L. Cleveland. 1994. Position and orientation independent transactivation by c-Myc. Cell. Mol. Biol. Res. 40:699-706.
132. Packham, G., and J. L. Cleveland. 1995. c-Myc and apoptosis. Biochim. Biophys. Acta 1242:11-28.
133. Packham, G., and J. L. Cleveland. 1997. Induction of ornithine decarboxylase by IL-3 is mediated by sequential c-Myc-independent and c-Myc-dependent pathways. Oncogene 15:1219-1232.
134. Packham, G., and J. L. Cleveland. 1994. Ornithine decarboxylase is a mediator of c-Myc-induced apoptosis. Mol. Cell. Biol. 14:5741-5747.
135. Pedersen, P. L. 1978. Tumor mitochondria and the bioenergetics of cancer cells. Prog. Exp. Tumor Res. 22:190-274.
136. Pena, A., C. D. Reddy, S. Wu, N. J. Hickok, E. P. Reddy, G. Yumet, D. R. Soprano, and K. J. Soprano. 1993. Regulation of human ornithine decarboxylase expression by the c-Myc.Max protein complex. J. Biol. Chem. 268:27277-27285.
137. Perez-Roger, I., D. L. C. Solomon, A. Sewing, and H. Land. 1997. Myc activation of cyclin E/Cdk2 kinase involves induction of cyclin E gene transcription and inhibition of p27Kip1 binding to newly formed complexes. Oncogene 14:2373-2381.
138. Peukert, K., P. Staller, A. Schneider, G. Carmichael, F. Hanel, and M. Eilers. 1997. An alternative pathway for gene regulation by Myc. EMBO J. 16:5672-5686.
139. Philipp, A., A. Schneider, I. Väsrik, K. Finke, Y. Xiong, D. Beach, K. Alitalo, and M. Eilers. 1994. Repression of cyclin D1: a novel function of MYC. Mol. Cell. Biol. 14:4032-4043.
140. Potter, M., and F. Wiener. 1992. Plasmacytomagenesis in mice: model of neoplastic development dependent upon chromosomal translocations. Carcinogenesis 13:1681-1697.
141. Prendergast, G. C., L. E. Diamond, D. Dahl, and M. D. Cole. 1990. The c-myc-regulated gene mr1 encodes plasminogen activator inhibitor 1. Mol. Cell. Biol. 10:1265-1269.
142. Prendergast, G. C., D. Lawe, and E. B. Ziff. 1991. Association of Myn, the murine homolog of max, with c-Myc stimulates methylation-sensitive DNA binding and ras cotransformation. Cell 65:395-407.
143. Prendergast, G. C., and E. B. Ziff. 1989. DNA-binding motif. Nature 341: 392.
144. Prendergast, G. C., and E. B. Ziff. 1991. Methylation-sensitive sequence-specific DNA binding by the c-Myc basic region. Science 251:186-189.
145. Prendergast, G. C, and E. B. Ziff. 1992. A new bind for Myc. Trends Genet. 8:91-96.
146. Pusch, O., G. Bernaschek, M. Eilers, and M. Hengstschlager. 1997. Activation of c-Myc uncouples DNA replication from activation of G1-cyclin-dependent kinases. Oncogene 15:649-656.
147. Pusch, O., T. Soucek, E. Hengstschlager-Ottnad, G. Bernaschek, and M. Hengstschlager. 1997. Cellular targets for activation by c-Myc include the DNA metabolism enzyme thymidine kinase. DNA Cell Biol. 16:737-747.
148. Reisman, D., N. Elkind, B. Roy, J. Beamon, and V. Rotter. 1993. c-Myc transactivates the p53 promoter through a required downstream CACGTG motif. Cell Growth Differ. 4:57-65.
149. Rempel, A., S. P. Mathupala, C. A. Griffin, A. L. Hawkins, and P. L. Pedersen. 1996. Glucose catabolism in cancer cells: amplification of the gene encoding type II hexokinase. Cancer Res 56:2468-2471.
150. Rosenwald, I. B., A. Lazariskaratzas, N. Sonenberg, and E. V. Schmidt. 1993. Elevated levels of cyclin D1 protein in response to increased expression of eukaryotic initiation factor 4E. Mol. Cell. Biol. 13:7358-7363.
151. Rosenwald, I. B., D. B. Rhoads, L. D. Callanan, K. J. Isselbacher, and E. V. Schmidt. 1993. Increased expression of eukaryotic translation initiation factors eIF-4E and eIF-2 alpha in response to growth induction by c-myc. Proc. Natl. Acad. Sci. USA 90:6175-6178.
152. Roussel, M. F. 1998. Key effectors of signal transduction and G1 progression. Adv. Cancer Res. 74:1-24.
153. Roussel, M. F., A. M. Theodoras, M. Pagano, and C. J. Sherr. 1995. Rescue of defective mitogenic signaling by D-type cyclins. Proc. Natl. Acad. Sci. USA 92:6837-6841.
154. Roy, A. L., C. Carruthers, T. Gutjahr, and R. G. Roeder. 1993. Direct role for Myc in transcription initiation mediated by interactions with TFII-I. Nature 365:359-361.
155. Roy, B., J. Beamon, E. Balint, and D. Reisman. 1994. Transactivation of the human p53 tumor suppressor gene by c-Myc/Max contributes to elevated mutant p53 expression in some tumors. Mol. Cell. Biol. 14:7805-7815.
156. Rudolph, B., R. Saffrich, J. Zwicker, B. Henglein, R. Muller, W. Ansorge, and M. Eilers. 1996. Activation of cyclin-dependent kinases by Myc mediates induction of cyclin A, but not apoptosis. EMBO J. 15:3065-3076.
157. Sakamuro, D., K. J. Elliott, R. Wechsler-Reya, and G. C. Prendergast. 1996. BIN1 is a novel MYC-interacting protein with features of a tumour suppressor. Nat. Genet. 14:69-77.
158. Sawyers, C. L., W. Callahan, and O. N. Witte. 1992. Dominant negative MYC blocks transformation by ABL oncogenes. Cell 70:901-910.
159. Schoenenberger, C. A., A. C. Andres, B. Groner, M. van der Valk, M. LeMeur, and P. Gerlinger. 1988. Targeted c-myc gene expression in mammary glands of transgenic mice induces mammary tumours with constitutive milk protein gene transcription. EMBO J. 7:169-175.
160. Schreiber-Agus, N., L. Chin, K. Chen, R. Torres, G. Rao, P. Guida, A. I. Skoultchi, and R. A. DePinho. 1995. An amino-terminal domain of Mxi1 mediates anti-Myc oncogenic activity and interacts with a homolog of the yeast transcriptional repressor SIN3. Cell 80:777-786.
161. Schreiber-Agus, N., Y. Meng, T. Hoang, H. J. Hou, K. Chen, R. Greenberg, C. Cordon-Canto, H. Lee, and R. DePinho. 1998. Role of Mxi1 in ageing organ systems and the regulation of normal and neoplastic growth. Nature 393:483-487.
162. Schuldiner, O., A. Eden, T. Ben-Yosef, O. Yanuka, G. Simchen, and N. Benvenisty. 1996. ECA39, a conserved gene regulated by c-Myc in mice, is involved in G1/S cell cycle regulation in yeast. Proc. Natl. Acad. Sci. USA 93:7143-7148.
163. Sedivy, J. M. Personal communication.
164. Semenza, G. L., B. H. Jiang, S. W. Leung, R. Passantino, J. P. Concordet, P. Maire, and A. Giallongo. 1996. Hypoxia response elements in the aldolase A, enolase 1, and lactate dehydrogenase A gene promoters contain essential binding sites for hypoxia-inducible factor 1. J. Biol. Chem. 271: 32529-32537.
165. Semenza, G. L., P. H. Roth, H. M. Fang, and G. L. Wang. 1994. Transcriptional regulation of genes encoding glycolytic enzymes by hypoxia-inducible factor 1. J. Biol. Chem. 269:23757-23763.
166. Serrano, M., A. W. Lin, M. E. McCurrach, D. Beach, and S. W. Lowe. 1997. Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16lNK4a. Cell 88:593-602.
167. Shapiro, D. N., V. Valentine, L. Eagle, X. Yin, S. W. Morris, and E. V. Prochownik. 1994. Assignment of the human MAD and MXI1 genes to chromosomes 2p12-p13 and 10q24-q25. Genomics 23:282-285.
168. Sheiness, D., L. Fanshier, and J. M. Bishop. 1978. Identification of nucleotide sequences which may encode the oncogenic capacity of avian retrovirus MC29. J. Virol. 28:600-610.
169. Shih, H. M., Z. Liu, and H. C. Towle. 1995. Two CACGTG motifs with proper spacing dictate the carbohydrate regulation of hepatic gene transcription. J. Biol. Chem. 270:21991-21997.
170. Shim, H., Y. S. Chun, B. C. Lewis, and C. V. Dang. 1998. A unique glucose-dependent apoptotic pathway induced by c-Myc. Proc. Natl. Acad. Sci. USA 95:1511-1516.
171. Shim, H., C. Dolde, B. C. Lewis, C. S. Wu, G. Dang, R. A. Jungmann, R. Dalla-Favera, and C. V. Dang. 1997. c-Myc transactivation of LDH-A: implications for tumor metabolism and growth. Proc. Natl. Acad. Sci. USA 94:6658-6663.
172. Shimizu, E., H. Shirasawa, K. Kodama, T. Sato, and B. Simizu. 1996. Expression, regulation and polymorphism of the mxi1 genes. Gene 176:45-48.
173. Shrivastava, A., S. Saleque, G. V. Kalpana, S. Artandi, S. P. Goff, and K. Calame. 1993. Inhibition of transcriptional regulator Yin-Yang-1 by association with c-Myc. Science 262:1889-1892.
174. Shrivastava, A., J. Yu, S. Artandi, and K. Calame. 1996. YY1 and c-Myc associate in vivo in a manner that depends on c-Myc levels. Proc. Natl. Acad. Sci. USA 93:10638-10641.
175. Skoda, R. C., S. F. Tsai, S. H. Orkin, and P. Leder. 1995. Expression of c-MYC under the control of GATA-1 regulatory sequences causes erythroleukemia in transgenic mice. J. Exp. Med. 181:1603-1613.
176. Smale, S. T., and D. Baltimore. 1989. The "initiator" as a transcription control element. Cell 57:103-113.
177. Smith-Sorensen, B., E. M. Hijmans, R. L. Beijersbergen, and R. Bernards. 1996. Functional analysis of Burkitt's lymphoma mutant c-Myc proteins. J. Biol. Chem. 271:5513-5518.
178. Sommer, A., K. Bousset, E. Kremmer, M. Austen, and B. Luscher. 1998. Identification and characterization of specific DNA-binding complexes containing members of the Myc/Max/Mad network of transcriptional regulators. J. Biol. Chem. 273:6632-6642.
179. Spencer, C. A., and M. Groudine. 1991. Control of c-myc regulation in normal and neoplastic cells. Adv. Cancer Res. 56:1-48.
180. Spotts, G. D., S. V. Patel, Q. Xiao, and S. R. Hann. 1997. Identification of downstream-initiated c-Myc proteins which are dominant-negative inhibitors of transactivation by full-length c-Myc proteins. Mol. Cell. Biol. 17: 1459-1468.
181. Tavtigian, S. V., S. D. Zabludoff, and B. J. Wold. 1994. Cloning of mid-G1 serum response genes and identification of a subset regulated by conditional myc expression. Mol. Biol. Cell. 5:375-388.
182. Tikhonenko, A. T., D. J. Black, and M. L. Linial. 1996. Viral Myc oncoproteins in infected fibroblasts down-modulate thrombospondin-1, a possible tumor suppressor gene. J. Biol. Chem. 271:30741-30747.
183. Torres, R., N. Schreiber-Agus, S. D. Morgenbesser, and R. A. DePinho. 1992. Myc and Max: a putative transcriptional complex in search of a cellular target. Curr. Opin. Cell Biol. 4:468-474.
184. Tsuneoka, M., F. Nakano, H. Ohgusu, and E. Mekada. 1997. c-myc activates RCC1 gene expression through E-box elements. Oncogene 14:2301-2311.
185. Valera, A, A. Pujol, X. Gregori, E. Riu, J. Visa, and F. Bosch. 1995. Evidence from transgenic mice that myc regulates hepatic glycolysis. FASEB J. 9:1067-1078.
186. Van Antwerp, M. E., D. G. Chen, C. Chang, and E. V. Prochownik. 1992. A point mutation in the MyoD basic domain imparts c-Myc-like properties Proc. Natl. Acad. Sci. USA 89:9010-9014.
187. Vastrik, I., T. P. Makela, P. J. Koskinen, J. Klefstrom, and K. Alitalo. 1994. Myc protein: partners and antagonists. Crit. Rev. Oncog. 5:59-68.
188. Versteeg, R., I. Noordermeer, M. Kruse-Wolters, D. Ruiter, and P. Schrier. 1988. c-myc down-regulates class I HLA expression in human melanomas. EMBO J. 7:1023-1029.
189. Vlach, J., S. Hennecke, K. Alevizopoulos, D. Conti, and B. Amati. 1996. Growth arrest by the cyclin-dependent kinase inhibitor p27Kip1 is abrogated by c-Myc. EMBO J. 15:6595-6604.
190. Wagner, A. J., J. M. Kokontis, and N. Hay. 1994. Myc-mediated apoptosis requires wild-type p53 in a manner independent of cell cycle arrest and the ability of p53 to induce p21waf1/cip1. Genes Dev. 8:2817-2830.
191. Wagner, A. J., C. Meyers, L. A. Laimins, and N. Hay. 1993. c-Myc induces the expression and activity of ornithine decarboxylase. Cell Growth Differ. 4:879-883.
192. Wagner, A. J., M. B. Small, and N. Hay. 1993. Myc-mediated apoptosis is blocked by ectopic expression of Bcl-2. Mol. Cell. Biol. 13:2432-2440.
193. Wang, G. L., B. H. Jiang, E. A. Rue, and G. L. Semenza. 1995. Hypoxiainducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O, tension. Proc. Natl. Acad. Sci. USA 92:5510-5514.
194. Wang, J., L. Y. Xie, S. Allan, D. Beach, and G. J. Hannon. 1998. Myc activates telomerase. Genes Dev. 12:1769-1774.
195. Warburg, O. 1930. The Metabolism of tumours. Constable, London, England.
196. Warburg, O. 1956. On the origin of cancer cells. Science 123:309-314.
197. Wechsler, D. S., A. L. Hawkins, X. Li, E. W. Jabs, C. A. Griffin, and C. V. Dang. 1994. Localization of the human Mxi1 transcription factor gene (MXI1) to chromosome 10q24-q25. Genomics 21:669-672.
198. Wechsler, D. S., C. A. Shelly, and C. V. Dang. 1996. Genomic organization of human MXI1, a putative tumor suppressor gene. Genomics 32:466-470.
199. Wechsler, D. S., C. A. Shelly, C. A. Petroff, and C. V. Dang. 1997. MXI1, a putative tumor suppressor gene, suppresses growth of human glioblastoma cells. Cancer Res. 57:4905-4912.
200. Weihua, X., D. J. Lindner, and D. V. Kalvakolanu. 1997. The interferon-inducible murine p48 (ISGF3gamma) gene is regulated by protooncogene c-myc. Proc. Natl. Acad. Sci. USA 94:7227-7232.
201. Wu, S., A. Pena, A. Korcz, D. R. Soprano, and K. J. Soprano. 1996. Overexpression of Mxi1 inhibits the induction of the human ornithine decarboxylase gene by the Myc/Max protein complex. Oncogene 12:621-629.
202. Yang, B.-S., T. J. Geddes, R. J. Pogulis, B. de Crombrugghe, and S. O. Freytag. 1991. Transcriptional suppression of cellular gene expression by c-Myc. Mol. Cell. Biol. 11:2291-2295.
203. Yang, B.-S., J. D. Gilbert, and S. O. Freytag. 1993. Overexpression of Myc suppresses CCAAT transcription factor/nuclear factor 1-dependent promoters in vivo. Mol. Cell. Biol. 13:3093-3102.
204. Yano, T., C. Sander, H. Clark, M. Dolezal, E. Jaffe, and M. Raffeld. 1993. Clustered mutations in the second exon of the MYC gene in sporadic Burkitt's lymphoma. Oncogene 8:2741-2748.
205. Zaffran, S., A. Chartier, P. Gallant, M. Astier, N. Arquier, D. Doherty, D. Gratecos, and M. Semeriva. 1998. A Drosophila RNA helicase gene, pitchoune, is required for cell growth and proliferation and is a potential target of d-Myc. Development 125:3571-3584.
206. Zervos, A. S., J. Gyuris, and R. Brent. 1993. Mxi1, a protein that specifically interacts with Max to hind Myc-Max recognition sites. Cell 72:223-232.
207. Zindy, F., C. M. Eischen, D. H. Randle, T. Kamijo, J. L. Cleveland, C. J. Sherr, and M. F. Roussel. 1998. Myc signaling via the ARF tumor suppressor regulates p53-dependent apoptosis and immortalization. Genes Dev. 12:2424-2433.